Across GLP-1 trials, about 60% of lost weight returns within the first year and roughly 75% returns over the longer curve, with the fastest regain in the early months. In semaglutides extension, about two-thirds returned within one year. The pattern reflects removal of appetite suppression after major weight loss
[DOI] [PubMed] [Google Scholar] 8.Sies H., Berndt C., Jones D.P
One state cautioned that if Medicaid marketing restrictions were modified, state Medicaid officials should closely monitor DSNP marketing materials, particularly those created for plans that use the material in multiple state markets
So now you get the attention of the news media, Hollywood, the comedians, all of them talking about Ozempic and weight loss capability
However, she warned that easier access must not mean weaker clinical oversight